TrovaGene, Inc. (NASDAQ:TROV)

CAPS Rating: 3 out of 5

Results 1 - 2 of 2

Recs

0
Member Avatar nancytroi (< 20) Submitted: 10/7/2013 11:40:15 AM : Outperform Start Price: $7.39 TROV Score: -45.88

New Diagnostic tests for cancer.

Recs

0
Member Avatar ctcarrigan33 (64.68) Submitted: 7/23/2013 12:14:52 PM : Outperform Start Price: $8.42 TROV Score: -54.09

Cheaper than blood tests or traditional tests, and their validation tests of the technology have been positive thus far

Results 1 - 2 of 2

Featured Broker Partners


Advertisement